NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2

Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and ...
Business Wire

Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced ...
ascopubs.org

An exploratory study of fruquintinib as second-line treatment for patients with advanced or metastatic biliary tract cancer.

Phase II study of nivolumab (anti-PD1), tadalafil, and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic ...
ascopubs.org

Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study

In this study, 3,319 unselected, pan-cancer Jordanian patients diagnosed between April 2021 and September 2022 received GGT. Pathogenic germline variant (PGV) frequency among patients who were ...
TravelMole

NordVPN x Saily study reveals a concerning number of leaked airline and hotel loyalty accounts

Exploratory NordVPN study reveals stolen airline and hotel loyalty accounts traded on dark web forums. Insights ...
PharmiWeb

MaaT Pharma Announces First Patient Randomized in…

IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...